Share on LinkedInShare on LinkedIn

ARTICLE · 25 FEBRUARY 2013

Nestlé / Pfizer Nutrition Merger Approved With Conditions

The Competition Tribunal has recently approved the South African leg of the global acquisition by Nestlé S.A. of the infant nutrition business of Pfizer Inc.

South AfricaAntitrust/Competition Law

On Monday, 11 February 2013, the Competition Tribunal (The "Tribunal") approved the South African leg of the global acquisition by Nestlé S.A. ("Nestlé") of the infant nutrition business of Pfizer Inc. ("Pfizer Nutrition"). Pfizer Nutrition's South African interests comprise, amongst other products, infant formula and follow on milks ("IFFO") marketed under the S-26 and SMA brands. In South Africa, Nestlé is similarly involved in the manufacturing and sales of IFFO under, amongst others, the NAN, Lactogen and Pelargon brands. Nestlé is a strong market leader in the IFFO markets in South Africa.

The merger was notified to the Competition Commission (the "Commission") on 8 June 2012. At the outset, Nestlé offered a remedy to address any change in market structure that would arise in South Africa from the global acquisition by Nestlé of Pfizer Nutrition. However, given the nature and the peculiarities of the infant milk formula market, Nestlé argued that a

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from